NCT03436498 Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients Status COMPLETED Phase PHASE1
NCT03434119 Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents Status TERMINATED Phase PHASE3
NCT03430063 A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer Status TERMINATED Phase PHASE2
NCT03428646 Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03415269 A Study of the Effect of 20 mg Ambroxol Hydrochloride on Acute Cough. Status COMPLETED Phase PHASE2
NCT03415178 Usability Study of the Commercial Auto-injector Device and the New Auto-injector Device (SYDNEY) in Patients With High or Very High CV Risk With Hypercholesterolemia Not Adequately Controlled With Their Lipid-Modifying Therapy Status COMPLETED Phase PHASE3
NCT03414736 A Study on Safety and Tolerability of SAR425899 in Overweight to Obese Subjects and Type 2 Diabetes Mellitus Patients Not Requiring Anti-Diabetic Pharmacotherapy With an Optional 6-month Safety Extension Period Status COMPLETED Phase PHASE1
NCT03414723 A Drug-Drug Interaction Study Between Sotagliflozin and Ramipril Status COMPLETED Phase PHASE1
NCT03409614 Combinations of Cemiplimab (Anti-PD-1 Antibody) and Platinum-based Doublet Chemotherapy in Patients With Lung Cancer Status COMPLETED Phase PHASE3
NCT03406663 The Korean TITRATION Study: Comparison of the Self-titration Methods for Glargine-300 Status COMPLETED Phase NA
NCT03406000 Phase 4 Study to Evaluate Treatment Optimization With Once-daily Insulin Glargine 300 U/mL Status COMPLETED Phase PHASE4
NCT03389893 Effect of Dupilumab (Anti-IL4Rα) on the Host-Microbe Interface in Atopic Dermatitis Status TERMINATED Phase PHASE4
NCT03387852 Evaluation of SAR440340 and as Combination Therapy With Dupilumab in Moderate-to-Severe Asthma Participants Status COMPLETED Phase PHASE2
NCT03387657 A Drug to Drug Interaction Study of Sotagliflozin With Hydrochlorothiazide Status COMPLETED Phase PHASE1
NCT03386344 Efficacy and Bone Safety of Sotagliflozin 400 and 200 mg Versus Placebo in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control Status TERMINATED Phase PHASE3
NCT03379558 Praluent® (Alirocumab) Pregnancy Exposure Registry: An OTIS Pregnancy Surveillance Study Status TERMINATED Phase N/A